Integral Molecular’s SARS-CoV-2 Reporter Virus Particles (RVPs) are replication-incompetent pseudotyped virus particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation. SARS-CoV-2 RVPs display antigenically correct spike protein on a heterologous virus core and carry a modified genome that expresses a convenient optical reporter gene within 24 hours of cellular infection. Protocols are provided for neutralization and infectivity assays.
Target cells are sold separately.
Visit the SARS-CoV-2 Reporter Virus Particles Information page for more details about this product. For tips on setting up your own neutralization assay, visit Pseudovirus Neutralization Assays: A How-to Guide for Getting Started.
| Product | SARS-CoV-2 Reporter Virus Particles (RVPs) |
| Catalog Number | RVP-763 |
| Strain | Delta Indian B.1.617.2 |
| Packaging | 20% FBS/DMEM |
| Recommended Input Range | 5-10µL per well (96-well plate) for ~20% infectivity in a flow assay* |
| Target Cell Line | 293T-hsACE2 Clonal Cell Line (Cat# C-HA102) |
| Lead time | 1-4 weeks |
| Shipping | Shipped on dry ice |
| Storage conditions | Store at -80°C (+/- 10°C) upon receipt |
| Size | 1.0 mL/vial |
| Warranty | Terms and Conditions (pdf) |
| SDS | SARS-CoV-2 RVP SDS (pdf) |
| Protocols | |
| Technical Data Sheets | SARS-CoV-2 Tech Data Sheets |
